EJNMMI Res 12:20 Koirala P, Chen SPR, Boer JC, Khalil ZG, Deceneux C, Goodchild G, Lu L, Faruck MO, Shalash AO et al (2023) Polymeric nanoparticles as a self-adjuvanting peptide vaccine delivery system: the role of shape
A 15-location clinic group can have wildly different staff, wait times, and provider attentiveness from one city to the next
Moreover, in subjects with diabetes who were at high risk of cardiovascular events, treatment with GLP-1R agonists based on the structure of endogenous GLP-1, namely liraglutide, semaglutide, albiglutide, and dulaglutide, has demonstrated reductions in major adverse cardiovascular events (MACEs) that appear to be unrelated to the glycemic effects of these agents (1316)
None is FDA-approved yet